Project

Medical device for reconstruction of spinal cord

Project Summary

⦁ Approximately 500,000 new spinal cord injury occurs worldwide. However, spinal cord injury is incurable yet. Thus, we developed a hydrogel patch (SuPine patch) that can form a favorable environment for regeneration of injured spinal cord neurons. SuPine patch is ready-to-use at emergency and does not cause any damage while implanting it on the spinal cord.
⦁ SuPine Patch is made up of FDA approved ingredients. With the FDA Humanitarian Device Exemption program, SuPine Patch may directly enter clinical trail phase III once it enters clinical trials.
⦁ SuPine Patch shows explicit motor recovery in pre-clinical trials.

Business Model

Revenue Model:
Licensing out to domestic and oversea pharmaceutical companies for FDA approval and market entrance.

Target Customer:
Pharmaceutical companies, neurosurgeon, Emergency

Distribution Channels:
Pharmaceutical companies, Hospitals, Army hospital

Main Achievements

Follow-up Investment:
Tapping VC and pharmaceutical companies for follow-up investment

Employment:
1

Dissertations or IP:
1 IP applied, PCT, 1 Journal

Other Achievements:
A Minister of Ministry of SMEs and Startups award,
Winner of 2017 U-Star ( $20,000 prize)